株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のインスリンデリバリー装置市場:動向と予測

Insulin Delivery Devices Market, by Product Type, Distribution Channel, and Geography - Global Trends, and Forecast to 2025

発行 Coherent Market Insights 商品コード 629628
出版日 ページ情報 英文 150 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.05円で換算しております。
Back to Top
世界のインスリンデリバリー装置市場:動向と予測 Insulin Delivery Devices Market, by Product Type, Distribution Channel, and Geography - Global Trends, and Forecast to 2025
出版日: 2018年02月28日 ページ情報: 英文 150 Pages
概要

当レポートでは、世界のインスリンデリバリー装置市場について調査分析し、市場規模と成長率、収益機会の可能性、市場促進要因・抑制要因、主要企業などについて、体系的な情報を提供しています。

第1章 調査目的と前提条件

第2章 市場範囲

第3章 市場力学、規制、動向分析

  • 市場力学
  • 影響分析
  • 技術進歩
  • 規制シナリオ
  • 産業動向
  • PEST分析
  • ファイブフォース分析

第4章 世界のインスリンデリバリー装置市場:製品タイプ別

  • イントロダクション
  • インスリンシリンジ
  • インスリンポンプ
  • インスリンペン
  • インスリンジェット式注射器

第5章 世界のインスリンデリバリー装置市場:流通経路別

  • イントロダクション
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第6章 世界のインスリンデリバリー装置市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • アフリカ
  • 中東

第7章 競合情勢

  • ヒートマップ分析
  • 市場シェア分析
  • 企業プロファイル
    • Novo Nordisk A/S
    • Becton, Dickinson and Company
    • Sanofi S.A.
    • F. Hoffmann-La Roche, Ltd.
    • Eli Lilly and Company
    • Medtronic, Plc
    • Ypsomed Holding AG
    • Animas Corporation
    • Insulet Corporation
  • アナリストの見解

第8章 セクション

目次

Direct subcutaneous insulin injection are the most common form of drug delivery, using a needle and syringe. There are different types of insulin delivery devices available including, syringes, pens, jet injectors, and insulin pumps. Insulin can be packaged in vials (bottles), cartridges or prefilled pens. However, several disposable and reusable pen devices have been developed that provide options for delivering rapid insulins and insulin premixes. Type or dosage of insulin can be changed according to the requirements to meet the individual needs of the patient Manufacturers are focusing on designing products, which are cost effective for people with diabetes which is expected to propel the growth of the insulin delivery devices market. For instance, in July 2017, Becton, Dickinson and Company launched BD Viva pen needles, have a highly engineered needle tip design for improved comfort and considered as the most cost-effective option for insulin-injecting people with diabetes in the UK.

Market Dynamics

The market is gaining significant traction due to increasing prevalence of diabetes, and new innovations in terms of design. According to the World Health Organization, in 2016, an estimated 422 million adults are living with diabetes globally. The major spike in incidence of type 2 diabetes over the last decade is mainly attributed to rising prevalence of obesity. However, high cost of some insulin delivery devices is expected to be a restraining factor for the market growth. For instance, insulin analogs supplied in cartridges or prefilled pens have a higher per unit of insulin cost than insulin analogs supplied in vials. For example, one vial (1000 U) of insulin costs US$ 105.95, which equates to a cost of 10.6 cents per unit of insulin. Five prefilled insulin pens containing insulin glulisine (total of 1500 U) have a total cost of US$ 201.01, equating to a cost of 13.4 cents per unit of insulin (26% over the cost of insulin glulisine supplied in a vial).

Key features of the study:

This report provides in-depth analysis of the insulin delivery devices market and its application, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: (2017–2025), considering 2016 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global insulin delivery devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies and future plans

Key companies covered as a part of this study include Novo Nordisk A/S, Becton, Dickinson and Company, Sanofi S.A.., F. Hoffmann-La Roche, Ltd., Eli Lilly and Company, Medtronic, Plc, Ypsomed Holding AG, Animas Corporation, and Insulet Corporation.

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion, and marketing tactics.

The global insulin delivery devices market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers of insulin delivery devices, research and consulting firms, new entrants, and financial analysts

Various strategy matrices used in analyzing the insulin delivery devices market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

  • Global Insulin Delivery Devices Market, By Product Type:
  • Insulin Syringes
  • Insulin Pens
  • Insulin Pumps
  • Insulin Jet Injectors
  • Global Insulin Delivery Devices Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Insulin Delivery Devices Market, By Geography:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Product Type:
  • Insulin Syringes
  • Insulin Pens
  • Insulin Pumps
  • Insulin Jet Injectors
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • By Product Type:
  • Insulin Syringes
  • Insulin Pens
  • Insulin Pumps
  • Insulin Jet Injectors
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Asia Pacific
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • By Product Type:
  • Insulin Syringes
  • Insulin Pens
  • Insulin Pumps
  • Insulin Jet Injectors
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • By Product Type:
  • Insulin Syringes
  • Insulin Pens
  • Insulin Pumps
  • Insulin Jet Injectors
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Product Type:
  • Insulin Syringes
  • Insulin Pens
  • Insulin Pumps
  • Insulin Jet Injectors
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Africa
  • By Country:
  • North Africa
  • Central Africa
  • South Africa
  • By Product Type:
  • Insulin Syringes
  • Insulin Pens
  • Insulin Pumps
  • Insulin Jet Injectors
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Company Profiles
  • Novo Nordisk A/S*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Future Plans
  • Becton, Dickinson and Company
  • Sanofi S.A.
  • F. Hoffmann-La Roche, Ltd.
  • Eli Lilly and Company
  • Medtronic, Plc
  • Ypsomed Holding AG
  • Animas Corporation
  • Insulet Corporation
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Industry Trends
  • PEST Analysis
  • PORTER'S Five Forces

4. Global Insulin Delivery Devices Market, By Product Type, 2017-2025, (US$ Million)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2016-2025
    • Segment Trends
  • Insulin Syringes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
  • Insulin Pumps
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
  • Insulin Pens
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
  • Insulin Jet Injectors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)

5. Global Insulin Delivery Devices Market, By Distribution Channel, 2017-2025, (US$ Million)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2016-2025
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)

6. Global Insulin Delivery Devices Market, By Region, 2017-2025, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, By Region, 2016-2025
  • North America
    • Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Country, 2015-2025, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Country, 2015-2025, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Country, 2015-2025, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Country, 2015-2025, (US$ Million)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Country, 2015-2025, (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Country, 2015-2025, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profiles
    • Novo Nordisk A/S
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Becton, Dickinson and Company
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Sanofi S.A.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • F. Hoffmann-La Roche, Ltd.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Eli Lilly and Company
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Medtronic, Plc
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Ypsomed Holding AG
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Animas Corporation
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Insulet Corporation
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top